Adverum Biotechnologies, Inc.

Ownership Transactions Reported by 26 Insiders

Symbol
ADVM on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
100 Cardinal Way, Redwood City, CA

Insiders trading volume in the past year

Adverum Biotechnologies, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Braden M. Leonard 10%+ Owner $17M +$2.4M +16.5% Jul 30, 2024
Julie Clark Chief Medical Officer $255K Sep 30, 2021
Angela Thedinga Chief Technology Officer $232K Aug 6, 2021
Brigit Riley Chief Scientific Officer $182K Mar 15, 2023
Mark Lupher Jr. Director $176K +$176K Jun 17, 2024
James Scopa Director $140K +$135K +2999% Jun 17, 2024
John Rakow SVP, Genl Counsel, Acting CFO $90.2K Sep 14, 2022
Setareh Seyedkazemi Chief Development Officer $73.8K -$9.43K -11.3% Aug 2, 2024
Richard Beckman Chief Medical Officer $60.5K Mar 1, 2023
Rupert D'Souza Chief Financial Officer $32.3K May 13, 2022
Dawn Svoronos Director Jun 17, 2024
Rabia Gurses Ozden Chief Medical Officer Aug 2, 2024
Nancy Pecota Principal Accounting Officer Jun 6, 2022
Mehdi Gasmi Director May 12, 2021
Thomas Woiwode Director May 12, 2021
Soo Hong Director Jun 17, 2024
Jack Anthony Thrift Interim CFO Sep 2, 2021
Reed Vaughn Tuckson Director Jun 17, 2024
Linda M. Rubinstein Chief Financial Officer Aug 2, 2024
Patrick Machado Director Jun 17, 2024
Scott M. Whitcup Director Jun 17, 2024
C. David Nicholson Director Jun 17, 2024
Christopher DeRespino Acting Chief Financial Officer and Chief Business Officer Jun 24, 2021
Peter Soparkar Chief Operating Officer Aug 2, 2024
Szilard Kiss Director Jun 17, 2024
Laurent Fischer CEO, PRESIDENT AND DIRECTOR, Director Aug 2, 2024

Recent Insider Transactions by Companies or Individuals for Adverum Biotechnologies, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.